Global rollout already happening - market still asleep
Mainz Biomed $MYNZ isn’t waiting for “someday.” ColoAlert is already being sold in 🇩🇪🇬🇧 labs and clinics -- real patients, real payments.
Yet Wall Street still values it like a pre-market biotech.
How long can a company with international commercialization stay under $10M cap?
When U.S. traders catch on, it won’t be a climb - it’ll be a breakout.
Not hype, just facts ignored by the tape.
$IVZ $AIT $AUR
🔥 Biotech gold hiding in plain sight - $MYNZ expanding its reachMainz Biomed just announced participation in another major medical conference - this time connecting directly with Europe’s leading gastro specialists.That’s how biotech credibility is built - handshake by handshake, city by city.ColoAlert isn’t a prototype - it’s already approved and used in 🇩🇪🇮🇹🇬🇧.And in a world where colorectal cancer is the #2 deadliest, the need for early, easy testing is exploding.Despite that, $MYNZ trades like a forgotten penny stock under $10M.Meanwhile, peers in the same field sit at multi-billion valuations.Once visibility meets momentum, it’s game on.Targeting $7 short-term, $11–12 on partnership or U.S. headline.📈 You don’t find asymmetry like this often - you recognize it when you see it.
#MYNZ #Biotech #Undervalued #ColoAlert #FDA
28 % borrow and 22 % short interest — the setup looks explosive 😤
Mainz Biomed N.V. (NASDAQ: $MYNZ)
gathering serious momentum near $1.40.
A confirmed breakout above $1.50 could trigger the next squeeze wave.
Retail sentiment over 70 % bullish adds fuel.
#MYNZ
28 % borrow and 22 % short interest — the setup looks explosive 😤
Mainz Biomed N.V. (NASDAQ: $MYNZ)
gathering serious momentum near $1.40.
A confirmed breakout above $1.50 could trigger the next squeeze wave.
Retail sentiment over 70 % bullish adds fuel.
#MYNZ
28 % borrow and 22 % short interest — the setup looks explosive 😤
Mainz Biomed N.V. (NASDAQ: $MYNZ)
gathering serious momentum near $1.40.
A confirmed breakout above $1.50 could trigger the next squeeze wave.
Retail sentiment over 70 % bullish adds fuel.
#MYNZ
28 % borrow and 22 % short interest — the setup looks explosive 😤
Mainz Biomed N.V. (NASDAQ: $MYNZ)
gathering serious momentum near $1.40.
A confirmed breakout above $1.50 could trigger the next squeeze wave.
Retail sentiment over 70 % bullish adds fuel.
#MYNZ
28 % borrow and 22 % short interest — the setup looks explosive 😤
Mainz Biomed N.V. (NASDAQ: $MYNZ)
gathering serious momentum near $1.40.
A confirmed breakout above $1.50 could trigger the next squeeze wave.
Retail sentiment over 70 % bullish adds fuel.
#MYNZ
PancAlert’s early validation buzz turning into a full-blown catalyst 🔥
Mainz Biomed N.V. (NASDAQ ) up +15 % as traders position for Q1 2025 results.
100 % sensitivity and 95 % specificity could redefine early diagnostics.
DCF target still $5.3 - biotech eyes wide open.
$MYNZ